| Product Code: ETC9960890 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The United States continues to see a significant influx of biotechnology import shipments, with key exporting countries including the UK, Finland, Germany, Canada, and Switzerland. The market concentration, as measured by the HHI, remained high in 2024, indicating a competitive landscape. The impressive compound annual growth rate (CAGR) of 85.39% from 2020 to 2024 underscores the strong demand for biotechnology products in the US. Furthermore, the growth rate of 12.29% from 2023 to 2024 indicates sustained momentum in the import market, offering opportunities for both domestic and international players in the biotechnology sector.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Biotechnology Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Biotechnology Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Biotechnology Market - Industry Life Cycle |
3.4 United States (US) Biotechnology Market - Porter's Five Forces |
3.5 United States (US) Biotechnology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.6 United States (US) Biotechnology Market Revenues & Volume Share, By Technology, 2021 & 2031F |
4 United States (US) Biotechnology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing investments in research and development (RD) in biotechnology |
4.2.2 Growing demand for personalized medicine and gene therapy |
4.2.3 Technological advancements in biotechnology leading to innovative products and services |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes for biotechnological products |
4.3.2 High cost of research and development and commercialization of biotechnology products |
5 United States (US) Biotechnology Market Trends |
6 United States (US) Biotechnology Market, By Types |
6.1 United States (US) Biotechnology Market, By Application |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Biotechnology Market Revenues & Volume, By Application, 2021- 2031F |
6.1.3 United States (US) Biotechnology Market Revenues & Volume, By Biopharmacy, 2021- 2031F |
6.1.4 United States (US) Biotechnology Market Revenues & Volume, By Bioservices, 2021- 2031F |
6.1.5 United States (US) Biotechnology Market Revenues & Volume, By Bioagri, 2021- 2031F |
6.1.6 United States (US) Biotechnology Market Revenues & Volume, By Bioindustrial, 2021- 2031F |
6.2 United States (US) Biotechnology Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Biotechnology Market Revenues & Volume, By Fermentation, 2021- 2031F |
6.2.3 United States (US) Biotechnology Market Revenues & Volume, By Tissue Regeneration, 2021- 2031F |
6.2.4 United States (US) Biotechnology Market Revenues & Volume, By PCR, 2021- 2031F |
6.2.5 United States (US) Biotechnology Market Revenues & Volume, By Nanobiotechnology, 2021- 2031F |
6.2.6 United States (US) Biotechnology Market Revenues & Volume, By DNA Sequencing & Others, 2021- 2031F |
7 United States (US) Biotechnology Market Import-Export Trade Statistics |
7.1 United States (US) Biotechnology Market Export to Major Countries |
7.2 United States (US) Biotechnology Market Imports from Major Countries |
8 United States (US) Biotechnology Market Key Performance Indicators |
8.1 Number of patents filed and granted for biotechnological innovations |
8.2 Percentage of biotechnology companies investing in RD compared to the previous year |
8.3 Adoption rate of new biotechnological products or therapies in the market |
8.4 Number of clinical trials initiated for biotechnology products |
8.5 Amount of funding raised by biotechnology startups in the US |
9 United States (US) Biotechnology Market - Opportunity Assessment |
9.1 United States (US) Biotechnology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.2 United States (US) Biotechnology Market Opportunity Assessment, By Technology, 2021 & 2031F |
10 United States (US) Biotechnology Market - Competitive Landscape |
10.1 United States (US) Biotechnology Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Biotechnology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here